459 related articles for article (PubMed ID: 30954271)
21. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor.
White MR; Crouch E; van Eijk M; Hartshorn M; Pemberton L; Tornoe I; Holmskov U; Hartshorn KL
Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L831-40. PubMed ID: 15608147
[TBL] [Abstract][Full Text] [Related]
22. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
[TBL] [Abstract][Full Text] [Related]
23. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.
Hartshorn KL; Webby R; White MR; Tecle T; Pan C; Boucher S; Moreland RJ; Crouch EC; Scheule RK
Respir Res; 2008 Sep; 9(1):65. PubMed ID: 18811961
[TBL] [Abstract][Full Text] [Related]
24. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles.
Hsieh MH; Beirag N; Murugaiah V; Chou YC; Kuo WS; Kao HF; Madan T; Kishore U; Wang JY
Front Immunol; 2021; 12():641360. PubMed ID: 34054808
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of inhibition of influenza by surfactant protein D revealed by large-scale molecular dynamics simulation.
Goh BC; Rynkiewicz MJ; Cafarella TR; White MR; Hartshorn KL; Allen K; Crouch EC; Calin O; Seeberger PH; Schulten K; Seaton BA
Biochemistry; 2013 Nov; 52(47):8527-38. PubMed ID: 24224757
[TBL] [Abstract][Full Text] [Related]
26. Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities.
Matos ADR; Wunderlich K; Schloer S; Schughart K; Geffers R; Seders M; Witt M; Christersson A; Wiewrodt R; Wiebe K; Barth P; Hocke A; Hippenstiel S; Hönzke K; Dittmer U; Sutter K; Rescher U; Rodionycheva S; Matera N; Ludwig S; Brunotte L
Emerg Microbes Infect; 2019; 8(1):1763-1776. PubMed ID: 31826721
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins.
Hartshorn KL; White MR; Shepherd V; Reid K; Jensenius JC; Crouch EC
Am J Physiol; 1997 Dec; 273(6):L1156-66. PubMed ID: 9435570
[TBL] [Abstract][Full Text] [Related]
28. Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: Down-modulation by H4 binding to C-reactive protein and Surfactant protein D.
Hsieh IN; White M; Hoeksema M; Deluna X; Hartshorn K
PLoS One; 2021; 16(2):e0247605. PubMed ID: 33635872
[TBL] [Abstract][Full Text] [Related]
29. Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera.
White MR; Crouch E; Chang D; Sastry K; Guo N; Engelich G; Takahashi K; Ezekowitz RA; Hartshorn KL
J Immunol; 2000 Aug; 165(4):2108-15. PubMed ID: 10925296
[TBL] [Abstract][Full Text] [Related]
30. Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.
Nikolaidis NM; White MR; Allen K; Tripathi S; Qi L; McDonald B; Taubenberger J; Seaton BA; McCormack FX; Crouch EC; Hartshorn KL
Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L1036-44. PubMed ID: 24705721
[TBL] [Abstract][Full Text] [Related]
31. Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses.
van Eijk M; Bruinsma L; Hartshorn KL; White MR; Rynkiewicz MJ; Seaton BA; Hemrika W; Romijn RA; van Balkom BW; Haagsman HP
J Biol Chem; 2011 Jun; 286(23):20137-51. PubMed ID: 21489996
[TBL] [Abstract][Full Text] [Related]
32. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor.
Xia C; Wolf JJ; Sun C; Xu M; Studstill CJ; Chen J; Ngo H; Zhu H; Hahm B
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915279
[TBL] [Abstract][Full Text] [Related]
33. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
[TBL] [Abstract][Full Text] [Related]
34. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection.
Wang J; Oberley-Deegan R; Wang S; Nikrad M; Funk CJ; Hartshorn KL; Mason RJ
J Immunol; 2009 Feb; 182(3):1296-304. PubMed ID: 19155475
[TBL] [Abstract][Full Text] [Related]
35. MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells.
Villalón-Letelier F; Brooks AG; Londrigan SL; Reading PC
mBio; 2021 Oct; 12(5):e0148421. PubMed ID: 34517760
[TBL] [Abstract][Full Text] [Related]
36. Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus.
White MR; Crouch E; Vesona J; Tacken PJ; Batenburg JJ; Leth-Larsen R; Holmskov U; Hartshorn KL
Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L606-16. PubMed ID: 15951332
[TBL] [Abstract][Full Text] [Related]
37. Antiviral Effect of Isoquercitrin against Influenza A Viral Infection via Modulating Hemagglutinin and Neuraminidase.
Cho WK; Lee MM; Ma JY
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361900
[TBL] [Abstract][Full Text] [Related]
38. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
39. Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells.
Sadewasser A; Paki K; Eichelbaum K; Bogdanow B; Saenger S; Budt M; Lesch M; Hinz KP; Herrmann A; Meyer TF; Karlas A; Selbach M; Wolff T
Mol Cell Proteomics; 2017 May; 16(5):728-742. PubMed ID: 28289176
[TBL] [Abstract][Full Text] [Related]
40. Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus.
Tecle T; White MR; Sorensen G; Gantz D; Kacak N; Holmskov U; Smith K; Crouch EC; Hartshorn KL
Biochem J; 2008 Jun; 412(2):323-9. PubMed ID: 18302538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
